BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

Free Newsletters
My Subscriptions

News by Subject
News by Disease
News by Date
Search News
Post Your News

Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Pharm Country
  Bio NC
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™


Company Profiles

Research Store

Research Events
Post an Event
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
Biotech/Pharma - Personnel (World)
Scientific Founder Of Intercept Pharmaceuticals (ICPT) Joins Tiziana Life Sciences Plc 9/12/2014
Medgenics, Inc. Announces The Appointment Of Scott Applebaum As Chief Legal Officer 9/10/2014
To-BBB technologies BV Taps A New CEO 9/9/2014
Bruno Lucidi New CEO In Karolinska Development AB Oncology Companies 9/8/2014
CollPlant Names Dr. Nadav Orr Vice President Research And Development 9/8/2014
Aptose Biosciences Recruits Stephen B. Howell, M.D. To Act In The Capacity Of Chief Medical Officer 9/8/2014
Pivotal Therapeutics Inc. Appoints Accomplished Healthcare And Investment Industry Veteran, Prakash Gowd, As Chief Financial Officer 9/8/2014
Ex-Genentech (RHHBY) Boss Resigns From Roche (RHHBY)'s Board; Fears Conflict Of Interest With New CEO Post At Google Inc.'s Calico 9/4/2014
Nabriva Therapeutics Appoints Dr. Colin Broom As CEO 9/3/2014
ICON Appoints Dr. Ira Spector As Executive Vice President, Analytics And Consulting 9/3/2014
Cerenis Therapeutics, Inc. Appoints Dr. Richard C. Pasternak As Chairman 9/3/2014
TiGenix Appoints Chief Medical Officer And Vice President Medical Affairs And New Product Commercialisation 9/2/2014
Shareholders Revolt Over GlaxoSmithKline (GSK)'s Plans To Shake Up Board; Investors Call For Speedy Departure Of Chairman Gent 9/2/2014
Sierk Pötting To Be The New CFO (Chief Financial Officer) Of BioNTech Group 9/2/2014
Amarantus BioSciences, Inc. Appoints Iain Ross To Board Of Directors 8/29/2014
Isogenica Limited Brings In A New CEO 8/28/2014
Moberg Pharma AB (Formerly known as Moberg Derma)’s Head Of U.S. Operations To Resign By End Of January 2015 8/28/2014
Appointment Announcement - Dr. Jeremy B. Desai, President and CEO, Apotex Inc. 8/27/2014
Nordic Nanovector: The Board Appoints Mr. Luigi Costa As New CEO 8/26/2014
Miriam Monge To Join Sartorius Stedim Biotech As Director Of Marketing For Integrated Solutions 8/26/2014
Pharmaceutical Executive Joins Mesoblast Limited (MSB.AX) As Chief Financial Officer 8/25/2014
Compugen Ltd. (CGEN) Appoints Mr. Ari Krashin As Chief Financial Officer 8/25/2014
More Exits From Ranbaxy Laboratories (RANBAXY.BO)' Top Management Team 8/21/2014
ELC Group Appoints Dr. Siddharth Chachad As Head Of Global Clinical Development And Medical Affairs 8/20/2014
Masters Speciality Pharma Appoints Partner Development Director 8/19/2014
Dr. Paul Blake To Take Executive Role As Chief Development Officer 8/15/2014
Forward Pharma Announces Appointment Of Dr. Jan G. J. Van De Winkel To Board Of Directors 8/13/2014
GE Healthcare Life SciencesOlivier Loeillot Appointed GM Asia Commercial Bioprocess 8/13/2014
Ex-Merck & Co., Inc. (MRK) Exec Appointed New President And CEO Of Medivir AB (MVRBF) 8/12/2014
Joel Sendek, Leading Wall Street Biotech Analyst, Joins Forward Pharma As Chief Financial Officer 8/11/2014
GlaxoSmithKline (GSK) Close To Poaching Royal Bank of Scotland (RBS)'s Sir Philip Hampton As Next Chairman 8/8/2014
WuXi PharmaTech Co., Ltd. Announces Appointment Of Walter Kwauk To Board 8/8/2014
Cortendo Appoints Matthew Pauls As CEO 8/7/2014
As Sanofi (France) (SAN.PA) Pushes to Grow Faster, A Top U.S. Exec Is Leaving 8/1/2014
Rafarma Pharmaceuticals Announces New President As Part Of Pending Acquisition Of Majority Interest 7/30/2014
ImaginAb, Inc. Appoints Roger Crystal, MD As Vice President of Business Development 7/28/2014
Amarantus BioSciences, Inc. Appoints Donald D. Huffman To Board Of Directors 7/28/2014
Management Reshuffle At Ranbaxy Laboratories (RANBAXY.BO): Arno Gessner Promoted, New R&D Head Named 7/28/2014
Bristol-Myers Squibb Company (BMY) Appoints Jitendra Tyagi As India Country Head 7/24/2014
Milestone Pharmaceuticals Appoints Chief Medical Officer 7/21/2014
Peptidream Announces The Appointment Of Dr. Keiichi Masuya As Chief Operating Officer (COO) At Peptidream Inc. 7/17/2014
Antibe Therapeutics Inc. Announces The Formation Of Its Clinical Advisory Board 7/17/2014
Teva Pharmaceutical Industries Limited (TEVA) Denies Shareholder Claim That A Chairman Has Been Selected 7/15/2014
Merck KGaA (MKGAF.PK) Hires A New Global Head Of R&D 7/15/2014
Immune Pharmaceuticals, Inc. Appoints Cameron Durrant, MD, MBA To Board Of Directors 7/14/2014
ScinoPharm President & CEO To Retire, Successor Named 7/11/2014
Prima Biomed (PRR.AX) Appoints New Chief Executive Officer 7/9/2014
Director Ying Han Resigns from WuXi PharmaTech Co., Ltd. Board 7/9/2014
Michael Balmuth Joins SV Life Sciences As Partner 7/8/2014
Oxford BioTherapeutics Appoints Dr. Eugen Leo As Head Of Clinical Development 7/8/2014
Oxford Immunotec Limited (OXFD) Appoints Louis O'Dea Chief Medical Officer 7/7/2014
Pharmalink AB Strengthens its Board Of Directors 7/7/2014
VolitionRX Announces New Chief Financial Officer 7/1/2014
ALK-Abello A/S Appoints New Executive Vice President For Product Supply 7/1/2014
ProSensa Holding N.V. (RNA) Strengthens Its Management Team And Supervisory Board With Key Appointments 6/30/2014
Ipsen (IPN.PA) Joins PHARNEXT's Board Of Directors 6/30/2014
Serial Entrepreneur Dr. Peter Hirth Joins Nuevolution As Corporate Advisor 6/26/2014
Helsinn Therapeutics (US) Inc. Strengthens Its Board Of Directors 6/25/2014
ThromboGenics NV (TBGNF) Rules Out Sale, CFO Calls It Quits 6/24/2014
With Boardroom Drama Behind Him, Teva Pharmaceutical Industries Limited (TEVA) Chairman Phillip Frost To Step Down By End Of The Year 6/19/2014
PSI Names Jim Kostka, Director of Project Management, North America 6/18/2014
Valeant Pharmaceuticals International (VRX) Announces Planned Management Departure 6/16/2014
Protalix Biotherapeutics, Inc. (PLX) CEO Will Retire This Year 6/13/2014
Pivotal Therapeutics Inc. Engages Kilmer Lucas For Cross-Border Investor Relations 6/12/2014
Foamix Establishes U.S. Subsidiary And Strengthens Executive Management With Appointment Of Senior U.S. Leadership Team 6/12/2014
Aerocrine Announces Leadership Changes 6/12/2014
AstraZeneca PLC (AZN) Investors Still Want To Link Executive Pay To Pipeline Delivery 6/11/2014
DNA Electronics Ltd. Appoints Nick McCooke As Chief Business Officer 6/10/2014
Israel Stem Cell Developer BrainStorm Cell Therapeutics Inc. Appoints Tony Fiorino, MD, PhD As CEO 6/9/2014
Chiltern International Ltd. And Society For Applied Pharmacological Sciences (SSFA) Announce The Appointment Of Dr. Marco Romano As President Of SSFA 6/9/2014
Immune Pharmaceuticals, Inc. Appoints Gad Berdugo To Board Of Directors And Karin Hehenberger, M.D., Ph.D To Senior Vice President 6/6/2014
Dieter Weinand Tapped To Be President Of Bayer HealthCare Pharmaceuticals (BAYA.F) 6/6/2014
Bayer AG (BAYZF)'s CEO To Quit In 2016, CFO Moves Over To Lead Strategy 6/5/2014
Teva Pharmaceutical Industries Limited (TEVA) Reorganizes, Makes Senior Leadership Changes 6/4/2014
Spinifex Pharmaceuticals Appoints Neuroscience Expert Dr Ronald Marcus As Chief Medical Officer 6/3/2014
Anergis Appoints Dr. Vanya Beltrami As Director Product Development 6/3/2014
Kymab Strengthens Management Team With Two Senior Appointments 6/3/2014
Novartis AG (NVS) Appoints Merck & Co., Inc. (MRK) Executive As Cancer Chief 6/3/2014
MGB Biopharma Limited Expands Scientific Advisory Board (SAB) With Medical Microbiologist Dr Stephanie Dancer 6/2/2014
Ascendis Pharma A/S Appoints Martin Auster, M.D., As Chief Business Officer 6/2/2014
SV Life Sciences Appoints Three New Venture Partners 6/2/2014
Gensignia Appoints CEO 5/30/2014
Bavarian Nordic (BAVA.CO) Taps Paul Chaplin, Ph.D. For President & CEO Post 5/29/2014
Chiltern International Ltd. Appoints Dr. Michael Wisniewski As Senior Executive Director, Biometrics 5/28/2014
Spinifex Pharmaceuticals Strengthens Scientific Advisory Board (SAB) With Experts In Chronic Pain 5/27/2014
Swedish Orphan BiovitrumAppoints Kirsti Gjellan As Senior Vice President Manufacturing Operations 5/27/2014
Domain Therapeutics Appoints Dr Youssef L. Bennani As Chairman Of The Board 5/27/2014
Appointment Of Jens Klein As Managing Director Of AMSilk GmbH 5/23/2014
AmpliPhi Biosciences Corporation (APHB) Announces Appointment of New Board Member 5/23/2014
Oncolytics Biotech Inc. (ONC.TO) Announces Nomination Of Two New Directors 5/22/2014
Dr. Brian Zambrowicz, Ph.D Has Joined Nuevolution As Director And Senior Scientific Advisor To The Board Of Directors 5/21/2014
Peter George Joins Board Of ErgoMed As Non-Executive Director 5/21/2014
Jazz Pharmaceuticals plc (JAZZ) Names Russell J. Cox To Position Of Chief Operating Officer 5/20/2014
Symphogen A/S Finds A New Home, Appoints Chief Manufacturing Officer 5/19/2014
Avastin And Lucentis Pioneer Joins Tiziana Life Sciences 5/19/2014
Pivotal Therapeutics Inc. Announces Changes To The Board Of Directors 5/15/2014
Karolinska Development AB Appoints New Board Directors 5/15/2014
World Leader In Movement Disorders Professor Ira Shoulson Joins PRANA Biotechnology (PRAN) Board 5/14/2014
Compugen Ltd. (CGEN) Appoints Mr. Avihai Shen Interim CFO 5/12/2014
Antibe Therapeutics Inc. Announces Addition To Its Board Of Directors And Grant Of Options 5/12/2014
MediWound (MDWD) Completes Recruitment Of Commercial Management Team In Europe 5/12/2014
PROMETHERA Biosciences S.A./N.V. Welcomes Frank Hazevoets As Chief Financial Officer 5/12/2014
Annette Clancy Joins Swedish Orphan Biovitrum's Board Of Directors 5/9/2014
Elekta Announces Changes To Its Executive Management Team 5/8/2014
DNA Electronics Ltd. Appoints Dr Steve Allen As Chief Operating Officer; Expands Product Development Team 5/8/2014
Scil Proteins GmbH Brings In A New CEO 5/8/2014
GW Pharmaceuticals Appoints Dr. Kenneth Sommerville As VP, Clinical Science 5/6/2014
Cobra Biologics Ltd. Appoints CSO 5/6/2014
QRxPharma Ltd. (QRXPY) COO Promoted To Top Post 5/2/2014
Marken Announces Appointment Of Chief Financial Officer Steve Menzies Joins As New CFO And Board Director 5/1/2014
Niklas Savander Assumes Role As Elekta's New President And CEO 5/1/2014
Endo Appoints Dr. Hemanth J. Varghese As Executive Vice President Of Corporate Development And Strategy 4/29/2014
Recipharm AB Appoints New Directors, Business Management To Further Strengthen European Sales Drive 4/29/2014
Kapil Dhingra, Former Head Of Roche Oncology, Joins Advanced Accelerator Applications Board Of Directors 4/29/2014
Galapagos NV (GLPG.BR) Announces Management Change 4/28/2014
AstraZeneca PLC (AZN) Investors Enraged, Revolt Over Executive Pay Plans 4/28/2014
Chugai Pharma USA, LLC. Announces Appointment Of Chief Medical Officer 4/25/2014
Bavarian Nordic (BAVA.CO) Welcomes Gerard Van Odijk As New Chairman Of The Board 4/25/2014
Pivotal Therapeutics Inc. Announces Resignation Of Directors 4/24/2014
Actavis (ACT) Announces Departure Of G. Frederick Wilkinson, President, Actavis Global R&D 4/21/2014
Lupin Pharmaceuticals, Inc. Appoints Theresa Stevens As Chief Corporate Development Officer 4/21/2014
Merck Serono's President & CEO Belén Garijo Has Been Appointed To Board Of Directors Of L'Oréal 4/18/2014
Results Of Election Of Employee Elected Member Of Zealand Pharma  (ZEAL.CO)’s Board Of Directors 4/17/2014
Professor Raymond Schinazi Joins Board Of reViral As Non-Executive Director 4/15/2014
New VP Sales, Michael Rossi, Appointed At Jubilant Draximage Inc. 4/10/2014
uniQure Announces Changes In Management Team 4/9/2014
Novartis AG (NVS) Names New Heads Of Alcon, Inc. (ACL), Sandoz, Inc. Units 4/9/2014
Atrium Innovations Announces Management Transition 4/8/2014
DBV Technologies Announces Creation Of US Subsidiary And Appoints Ms. Susanna Mesa As Vice President Of Finance, U.S. Investor Relations & Strategy 4/7/2014
e-Therapeutics plc Announces Directorate Change 4/7/2014
e-Therapeutics plc Announces That Steve Medlicott Has Been Appointed Finance Director 4/7/2014
Global Regulatory Affairs Specialist ELC Group Appoints Senior Regulatory Expert 4/3/2014
Top Novartis AG (NVS) Execs In Japan Quit Over Cancer Drug Scandal, Replacements Appointed 4/3/2014
Immune Pharmaceuticals, Inc. CEO Announces New Operational Leadership Team 4/2/2014
Proposal Of The Election Committee Regarding Members Of The Board Etc. For Vitrolife (VITR.ST) 3/31/2014
Meda AB (MEDA-A.ST) Release: Nomination Committee’s Proposal For Composition Of The Board 3/28/2014
Cambridge-Based Regenerys Brings In Ex-GE Healthcare Exec For Top Post 3/28/2014
Adaptimmune Ltd. Announces Full-Time Appointment Of James Noble As Chief Executive Officer 3/26/2014
Immunocore Limited Announces Re-Organisation Of Its Executive Management To Support Business Growth 3/26/2014
AstraZeneca PLC (AZN) CEO Gets A Bigger Bonus In 2013 3/25/2014
In Another Top Management Move, Takeda Pharmaceutical Co. Ltd. (TKPYY) Appoints New Emerging Markets Chief 3/20/2014
CiToxLAB Appoints John C. Kapeghian As Senior Director Of Toxicology In North America 3/18/2014
Medivir AB (MVRBF): The Nomination Committee’s Proposal, With Reference To The Upcoming 2014 Annual General Meeting, For A New Board Of Directors 3/14/2014
Formycon AG Appoints Top U.S. Pharmaceuticals Manager Bernhard Hampl To The Advisory Board 3/13/2014
NovImmune SA Appoints Andrew J. Oakley As CFO 3/12/2014
Novella Clinical Names Dr. Chris Smyth Managing Director Of European And Asian Operations 3/11/2014
Award-Winning Scientist Dr. Susan M. Dallabrida Promoted To Vice President Of Clinical Science And Consulting Of PHT Corporation 3/11/2014
Royal DSM Proposes Appointment Of New Chief Financial Officer 3/10/2014
Veloxis Pharmaceuticals A/S (VELO) Promotes John Weinberg To Chief Operating Officer 3/6/2014
Teva Pharmaceutical Industries Limited (TEVA) Returns To Roots After "Nuthouse" Board Ousts CEO 3/6/2014
Novogen Limited (NVGN) Appoints New Board Members And Strategic Advisor To Support Transition To Clinical Development And Growing International Presence 3/4/2014
IP Group Appoints Professor Lynn Gladden As Non-Executive Director 3/4/2014
Novasep Appoints CEO Michel Spagnol As Chairman Of The Supervisory Board 3/4/2014
Amakem Therapeutics Appoints Dr. James Tsai Of The Yale School Of Medicine To Its Clinical Advisory Board 3/4/2014
BeiGene Co.,Ltd Announces Addition Of Dr. Ronald Levy To Scientific Advisory Board 3/3/2014
Canbex Therapeutics Announces The Appointment Of New Chief Medical Officer 3/3/2014
PSI CRO Names Dr. Gabriele Schmoetzer, Head Of Regulatory Affairs Germany 2/26/2014
WuXi PharmaTech Co., Ltd. Announces Appointment Of Dr. Hua Mu To Head Product Development Service And Partnership Business Unit 2/26/2014
Jazz Pharmaceuticals plc (JAZZ) Announces Management Change 2/26/2014
Faculty Of 1000 Appoints New CEO 2/25/2014
Alchemia Appoints Thomas Liquard As Chief Executive Officer 2/24/2014
INC Research, Inc. Appoints 30-Year Industry Veteran Jane Winter To Lead Global Consulting Practice 2/24/2014
Laurence Burke Joins Exco Intouch As Vice President Of Operations 2/19/2014
Alcobra (ADHD) Appoints J.P. Morgan Banker Dr. Tomer Berkovitz As Chief Financial Officer 2/19/2014
Lupin Ltd. (LUPN.BO) Appoints Dr. Maurice Chagnaud As President-Europe & Head Of Inhalation Strategy 2/18/2014
Complementing Recommendation By The Nomination Committee Of Oriola-KD Corporation Concerning The Board Of Directors To Be Elected By The 2014 Annual General Meeting 2/18/2014
Avillion Appoints Dr. Allison Jeynes-Ellis As Chief Executive Officer 2/18/2014
Emperra Appoints Christian Krey As New CEO To Market ESYSTA® Telediabetology System 2/11/2014
Medical Key Opinion Leaders In Preeclampsia Join Pluristem Therapeutics (PSTI)'s Steering Committee 2/11/2014
Novogen Limited (NVGN) Announces Key Appointments To Drive Development Of Anti-Tropomyosin Drug Platform 2/5/2014
Pluristem Therapeutics (PSTI) Strengthens Executive Team; Announces Senior Executive Appointments 2/5/2014
Amarin Corporation PLC (AMRN) Announces Promotion Of Aaron Berg To Senior Vice President, Marketing And Sales 2/4/2014
NicOx SA (COX.PA) Appoints Evelyne Nguyen As CFO 2/4/2014
Aesica Appoints Ian Muir To Newly Created Commercial Managing Director Position 2/3/2014
Sartorius AG Appoints Internationally Experienced Laboratory Manager To Join Its Top Management Team 1/30/2014
Novartis AG (NVS) Keeps CEO Pay Steady, But Incoming Chairman Pay Drops 1/29/2014
Merck KGaA (MKGAF.PK) Shaken Due To CFO's Surprise Exit 1/28/2014
Lanxess AG (LXS.F) Names Former CFO Zachert As CEO Displacing Heitmann 1/27/2014
Susan Kilsby To Succeed Matthew Emmens As Chairman Of Shire 1/23/2014
Teva Pharmaceutical Industries Limited (TEVA) To Reduce Size Of Its Board, Add Experts 1/23/2014
Compugen Ltd. (CGEN) Announces Addition Of Prof. Drew Pardoll To Its Scientific Advisory Board 1/21/2014
Imugene Limited (IMU.AX) Appoints Distinguished Scientists To Scientific Advisory Board 1/20/2014
Alacrita Appoints Pierre Dodion As An Associate Partner 1/20/2014
NextPharma Technologies Continues To Strengthen Its Business With Three Senior Appointments 1/20/2014
INC Research, Inc. Strengthens Oncology Team With Two Key Appointments 1/20/2014
ICON Appoints Dr. Dariush Elahi As Head Of Metabolic Research, Early Phase 1/20/2014
Novasep Attracts Top Talent To Complete Its Executive Team 1/16/2014
Oxford BioTherapeutics Appoints Thomas C Reynolds MD, PhD To Its Board Of Directors 1/15/2014
Actavis (ACT) Appoints Industry Veterans To Lead U.S. Specialty Brands Business Units 1/14/2014
Tyco Files Proxy Statement And Proposes Election Of New Directors 1/13/2014
ShangPharma Appoints Pharmaceutical Executive Dr. Mitchell Reff Chief Biologics Officer 1/13/2014
Alcobra (ADHD) Strengthens Management Team With Addition Of Industry Veteran David C. Baker As Chief Commercial Officer 1/13/2014
Novartis AG (NVS) Head, Herve Hoppenot, Flys The Coop To Become CEO Of Incyte Corporation (INCY) 1/13/2014
Galderma Pharma S.A. Announces CEO For North American Operations 1/10/2014
Ascendis Pharma A/S Announces The Appointment Of Thomas P. Soloway As Chief Financial Officer 1/10/2014
Heptares Appoints Tim Tasker As Chief Medical Officer 1/9/2014
Priaxon Appoints Dr Constance Hoefer As Chief Development Officer 1/9/2014
Teva Pharmaceutical Industries Limited (TEVA) Confirms Rumor, Picks Turnaround Specialist As New CEO 1/9/2014
Santaris Pharma A/S Announces Appointment Of J. Donald Debethizy As President And Chief Executive Officer 1/8/2014
SCM Pharma Limited Strengthens U.S. Presence 1/7/2014